First Interstate Bank’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
5,964
+299
+5% +$64.3K 0.08% 86
2026
Q1
$1.23M Sell
5,665
-1,686
-23% -$374K 0.07% 86
2025
Q4
$1.68M Sell
7,351
-594
-7% -$135K 0.09% 81
2025
Q3
$1.84M Buy
7,945
+712
+10% +$145K 0.1% 75
2025
Q2
$1.34M Sell
7,233
-587
-8% -$109K 0.08% 78
2025
Q1
$1.64M Buy
7,820
+99
+1% +$19.2K 0.1% 71
2024
Q4
$1.37M Buy
7,721
+59
+0.8% +$10.8K 0.08% 80
2024
Q3
$1.51M Buy
7,662
+34
+0.4% +$6.35K 0.09% 78
2024
Q2
$1.31M Sell
7,628
-457
-6% -$75.7K 0.09% 79
2024
Q1
$1.47M Buy
8,085
+666
+9% +$115K 0.1% 75
2023
Q4
$1.15M Sell
7,419
-586
-7% -$85.4K 0.09% 81
2023
Q3
$1.19M Sell
8,005
-43
-0.5% -$6.31K 0.1% 78
2023
Q2
$1.08M Sell
8,048
-1,055
-12% -$155K 0.09% 83
2023
Q1
$1.45M Sell
9,103
-1,260
-12% -$193K 0.11% 75
2022
Q4
$1.68M Sell
10,363
-284
-3% -$43.5K 0.12% 76
2022
Q3
$1.43M Buy
10,647
+590
+6% +$84.7K 0.12% 72
2022
Q2
$1.54M Buy
10,057
+7,617
+312% +$1.16M 0.12% 75
2022
Q1
$395K Buy
2,440
+80
+3% +$11.6K 0.04% 91
2021
Q4
$320K Sell
2,360
-40
-2% -$4.72K 0.03% 89
2021
Q3
$259K Buy
2,400
+122
+5% +$13.9K 0.03% 95
2021
Q2
$256K Buy
+2,278
New +$257K 0.03% 98
2020
Q4
$264K Buy
2,465
+60
+2% +$5.77K 0.04% 90
2020
Q3
$211K Sell
2,405
-1,461
-38% -$138K 0.03% 98
2020
Q2
$380K Buy
3,866
+136
+4% +$12K 0.05% 122
2020
Q1
$285K Sell
3,730
-400
-10% -$34.1K 0.07% 128
2019
Q4
$365K Buy
4,130
+500
+14% +$41.5K 0.08% 126
2019
Q3
$274K Sell
3,630
-2,620
-42% -$180K 0.06% 151
2019
Q2
$455K Sell
6,250
-29
-0.5% -$2.28K 0.1% 115
2019
Q1
$506K Sell
6,279
-220
-3% -$18K 0.11% 111
2018
Q4
$600K Sell
6,499
-125
-2% -$11K 0.15% 91
2018
Q3
$627K Sell
6,624
-3,010
-31% -$285K 0.13% 101
2018
Q2
$893K Sell
9,634
-309
-3% -$30.2K 0.2% 78
2018
Q1
$941K Sell
9,943
-2,196
-18% -$241K 0.21% 76
2017
Q4
$1.17M Buy
12,139
+1,800
+17% +$170K 0.25% 65
2017
Q3
$919K Buy
10,339
+1,330
+15% +$101K 0.2% 78
2017
Q2
$653K Hold
9,009
0.14% 96
2017
Q1
$587K Hold
9,009
0.12% 98
2016
Q4
$564K Sell
9,009
-7,604
-46% -$464K 0.11% 106
2016
Q3
$1.05M Sell
16,613
-4,751
-22% -$308K 0.21% 74
2016
Q2
$1.32M Sell
21,364
-780
-4% -$47.5K 0.28% 66
2016
Q1
$1.26M Buy
22,144
+535
+2% +$29.8K 0.27% 65
2015
Q4
$1.28M Sell
21,609
-3,590
-14% -$207K 0.27% 67
2015
Q3
$1.37M Buy
25,199
+19,770
+364% +$1.29M 0.29% 58
2015
Q2
$365K Hold
5,429
0.06% 78
2015
Q1
$318K Sell
5,429
-180
-3% -$10.9K 0.05% 77
2014
Q4
$367K Buy
5,609
+1,183
+27% +$74.6K 0.06% 71
2014
Q3
$256K Sell
4,426
-473
-10% -$26.3K 0.05% 76
2014
Q2
$277K Buy
+4,899
New +$257K 0.06% 78

Other funds holding ABBV

First Interstate Bank's ABBV Position: Q2 2026 in Review

First Interstate Bank increased its AbbVie (ABBV) stake by 5.3% in Q2 2026, buying an estimated $64.3K and bringing the position to 5,964 shares worth $1.5M. The position accounts for 0.08% of the portfolio, ranked #86.

First Interstate Bank first reported a position in ABBV in Q2 2014 and has held it in 48 quarters since. The position peaked at $1.84M in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • First Interstate Bank held 5,964 shares of AbbVie worth $1.5M as of Q2 2026.
  • First Interstate Bank bought 299 AbbVie shares in Q2 2026, an estimated $64.3K.
  • AbbVie made up 0.08% of First Interstate Bank's portfolio in Q2 2026, its #86 holding.
  • First Interstate Bank first reported a position in AbbVie in Q2 2014 and has held it in 48 quarters since.
  • First Interstate Bank's AbbVie position peaked at $1.84M in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on First Interstate Bank's 13F filing for Q2 2026, filed 24 Jul 2026.